Free Access
| Issue |
Med Sci (Paris)
Volume 38, Number 8-9, Août-Septembre 2022
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 740 - 742 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2022114 | |
| Published online | 12 September 2022 | |
- Rantala ES, Hernberg MM, Piperno-Neumann S, et al. Metastatic uveal melanoma: The final frontier. Prog Retin Eye Res 2022; 101041. [CrossRef] [Google Scholar]
- Kujala E, Mäkitie T, Kivelä T Very long-term prognosis of patients with malignant uveal melanoma. Invest. Ophthalmo Vis Sci 2003 ; 44 : 4651–4659. [CrossRef] [Google Scholar]
- Nathan P, Hassel JC, Rutkowski P, et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med 2021; 385 : 1196–206. [CrossRef] [PubMed] [Google Scholar]
- Pandiani C, Strub T, Nottet N, et al. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death Differ 2021; 28 : 1990–2000. [CrossRef] [PubMed] [Google Scholar]
- Neklesa T, Winkler J. and Crews C. Targeted protein degradation by PROTACs. Pharmacol Ther 2017; 174: 138–44. [CrossRef] [PubMed] [Google Scholar]
- Baron M. An overview of the Notch signalling pathway. Semin Cell Dev Biol 2003 ; 14 : 113–119. [CrossRef] [PubMed] [Google Scholar]
- Kopan R, Ilagan MX. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 2009 ; 137 : 216–233. [CrossRef] [PubMed] [Google Scholar]
- Xu Y, Liu X, Zhang H. et al. Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer. Oncol Rep 2018 ; 40 : 1261–1274. [PubMed] [Google Scholar]
- Haapa-Paananen S, Kiviluoto S, Waltari M et al. HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation. Oncogene 2012 ; 31 : 1299–1310. [CrossRef] [PubMed] [Google Scholar]
- Bertolotto C. Cutaneous and uveal melanoma: two different cancers in therapeutic needs. CR Biol 2021; 344 : 219–31. [Google Scholar]
- Churcher I. Protac-induced protein degradation in drug discovery: breaking the Rules or just making new ones ?. J Med Chem 2018 ; 61 : 444–452. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.